NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Senseonics Holdings, Inc. (SENS) Stock Analysis

Senseonics Holdings, Inc. (SENS) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

SENS

$7.97

−$0.24 (−2.92%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SENS with… →

SENS Key Statistics

As of Oct 21, 2026
Trading
Open
$8.23
Previous Close
$8.21
Day's Range
7.94–8.31
52-Week Range
4.79–10.64
Volume
530.39K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.03
Valuation
Market Cap
$421.41M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
8.68
EPS (ttm)Profit attributable to each share over the last twelve months.
−2.23
Financials (FY)
Revenue (FY)
$35.26M+56.89%
Net Income (FY)
−$69.11M
Profit marginThe share of revenue left as profit after all costs and taxes.
−225.34%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
52.87M
1-Year Return
+4.46%
Dividend and dates
Earnings Date
November 9, 2026
Avg Volume
691.03K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, SENS closed at $7.97, +4.46% over 1 year.

Senseonics Holdings, Inc. (SENS) has a market capitalization of $421.41M.

In fiscal 2025, SENS reported revenue of $35.26M.

SENS Stock Return by Calendar Year

Senseonics Holdings, Inc. (SENS) 10-year return: what $10,000 became

1 year
$10,000 $10,446
+4.46%
5 years
$10,000 $1,113
−88.87%
10 years
$10,000 $1,324
−86.76%

If you had invested $10,000 in Senseonics Holdings, Inc. (SENS) 10 years ago, at the close on October 21, 2016, it would have been worth $1,324 at the close on October 21, 2026: −86.76% in total, −18.31% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+44.38%
2025−47.23%
2024−8.25%
2023−44.66%
2022−61.42%
2021+206.19%
2020−4.80%
2019−64.63%
2018−2.63%
2017−0.37%
2016 (partial year)−13.87%

As of October 21, 2026.

SENS Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$35.26M−$69.11M−196.0%
2024$22.47M−$78.62M−349.8%
2023$22.39M−$60.39M−269.7%
2022$16.39M$142.12M867.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$35.26M$15.76M−$68.34M−$69.11M−196.0%
2024$22.47M$533.00K−$74.84M−$78.62M−349.8%
2023$22.39M$3.09M−$75.60M−$60.39M−269.7%
2022$16.39M$2.73M−$68.63M$142.12M867.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SENS Valuation vs Medical Devices Median

Median of 145 stocks
MetricSENSMedical Devices medianvs median
P/S ratio8.682.533.4x the median
Profit margin−225.34%−14.78%210.6 pts below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 15 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Senseonics Holdings, Inc. (SENS) is capitalised at $421.41M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 130 employees.

SENS last closed at $7.97 on October 21, 2026. That is −$0.24 (−2.92%) against the previous close. Over the past 52 weeks the price has ranged from $4.79 to $10.64. The latest close sits 66.39% above that 52-week low.

Financial Health

In fiscal 2025, Senseonics Holdings, Inc. reported revenue of $35.26M. That is +56.89% against the prior fiscal year, when revenue was $22.47M. The same year closed with a net loss of $69.11M. Profit margin runs at −225.34%. That is 210.6 percentage points below the Medical Devices median of −14.78%. Earnings per share on a trailing basis come to −2.23.

Across the 4 fiscal years on file, revenue moves from $16.39M in 2022 to $35.26M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 8.68 times revenue. On price-to-sales that is 3.4 times the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

The trailing one-year total return is +4.46%. Measured over 10 years, that is −18.31% a year compounded. Beta against the wider market is reported at 1.03. Annualized volatility over the trailing 10 years is 93.63%.

Growth & Income

The record shows no dividend for SENS.

The strongest complete calendar year on file is 2021 at +206.19%; the weakest is 2019 at −64.63%. Of the 9 complete calendar years on file, 1 finished higher. So far in 2026 the total return is +44.38%.

Peer Comparison

Senseonics Holdings, Inc. (SENS) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Senseonics Holdings, Inc. SENS $421.41M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Senseonics Holdings, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Senseonics Holdings, Inc.

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Visit website →